Dipyridamole Completed Phase 4 Trials for Atherosclerosis / Ischemia-Reperfusion Injury Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00457405Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?